|
Market Closed -
Börse Stuttgart
15:46:14 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 129.48 EUR | -0.43% |
|
+1.90% | +22.93% |
| 09-03 | AbbVie's blood cancer therapy lowers disease progression, death risk in trial | RE |
| 09-01 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
Stock exchange
Börse Stuttgart
GIS 129.48 €
-0.43%
0
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| GILD | 151.00USD | -0.15% | 933M $ | ||
CBOE
| GILD | 150.99USD | -0.14% | 26.6M $ | |
|
Tradegate
| GIS | 129.98EUR | -0.05% | 262K € | |
|
London S.E.
| 0QYQ | 149.50USD | 0.00% | 145K $ | |
|
Boerse Muenchen
| GIS | 129.78EUR | -0.11% | 31.54K € | |
|
Wiener Boerse
| GILD | 129.54EUR | +0.28% | 23.58K € | |
|
Mexican S.E.
| GILD * | 2,553.46MXN | +0.94% | 424K $ | |
|
Xetra
| GIS | 129.72EUR | +0.43% | 15.57K € | |
|
CBOE
| 0QYQ | 129.42EUR | +0.14% | 10.35K € | |
|
Borsa Italiana
| 1GILD | 125.66EUR | -1.63% | 5.91K € | |
|
Swiss Exchange
| GILD | 121.08CHF | +1.25% | 0 CHF | |
|
Santiago S.E.
| GILDCL | 134,210.00CLP | 0.00% | 0 $ | |
|
Deutsche Boerse AG
| GIS | 127.84EUR | -0.75% | 0 € | |
|
Lima
| GILDUS | 146.34USD | 0.00% | 0 $ | |
|
Santiago S.E.
| GILD | 146.74USD | 0.00% | 0 $ | |
|
Börse Stuttgart
| GIS | 129.48EUR | -0.43% | 0 € | |
|
Swiss Exchange
| GILD | 149.46USD | +0.20% | 0 $ | |
|
CBOE
| 127.63EUR | 0.00% | 0 € | ||
| GILD34 | 64.26BRL | +0.02% | 109K R$ | ||
| GILD | 59,675.00ARS | -0.58% | 11.76M $ | ||
|
Buenos Aires S.E.
| GILDD | 38.93USD | +0.31% | 77.86 $ | |
| GILD | 30.42CAD | -0.20% | 138K $ | ||
|
Deutsche Boerse AG
| GIS0 | 18.80EUR | +1.08% | 0 € |
Quotes 5-day view: Gilead Sciences, Inc.
Delayed Quote Börse Stuttgart
| 2026-08-31 | 2026-09-01 | 2026-09-02 | 2026-09-03 | 2026-09-04 | |
|---|---|---|---|---|---|
| Last | €125.82 | €128.76 | €129.30 | €130.04 | €129.48 |
| Volume | 1 | 205 | 155 | 105 | 0 |
| Change | +0.22% | +2.34% | +0.42% | +0.57% | -0.43% |
| Opening | €125.38 | €125.80 | €129.12 | €128.56 | €130.06 |
| High | €126.26 | €128.76 | €129.92 | €130.04 | €130.06 |
| Low | €124.30 | €125.28 | €128.80 | €127.80 | €128.98 |
Performance
| 1 week | +3.14% | ||
| Current month | +2.91% | ||
| 1 month | +11.64% | ||
| 3 months | +16.48% | ||
| 6 months | +1.70% | ||
| Current year | +22.40% | ||
| 1 year | +32.94% | ||
| 3 years | +82.11% | ||
| 5 years | +113.49% | ||
| 10 years | +88.32% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
187,227,028,629
Market Cap (USD)
187,227,028,629
Net sales (USD)
29,443,000,000
Free-Float
99.88 %
Free-Float capitalization (EUR)
217,321,483,783
Free-Float capitalization (USD)
187,005,136,796
Average Daily Capital Traded
0%
Indicators
Moving average 5 days
127.89
Moving average 20 days
123.63
Moving average 50 days
118.32
Moving average 100 days
115.16
Price spread / (MMA5)
-1.23%
Price spread / (MMA20)
-4.52%
Price spread / (MMA50)
-8.62%
Price spread / (MMA100)
-11.06%
RSI 9 days
72.34
RSI 14 days
68.7
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.43% | +1.90% | +32.94% | +82.11% | 187B | |
| -0.88% | -2.15% | +54.71% | +106.31% | 1,024B | |
| -1.15% | +2.68% | +53.97% | +71.50% | 663B | |
| -1.44% | +0.38% | +20.40% | +73.05% | 453B | |
| +0.14% | -0.47% | +29.49% | +38.56% | 352B | |
| -1.33% | +4.72% | +24.69% | +45.55% | 304B | |
| -1.15% | +0.30% | -1.49% | +12.31% | 252B | |
| -1.55% | +1.11% | +56.10% | +70.32% | 236B | |
| -0.88% | +1.15% | -17.09% | -54.39% | 206B | |
| -0.15% | +3.65% | +33.90% | +96.99% | 187B | |
| Average | -0.99% | +1.09% | +28.76% | +54.23% | 386.56B | |
| Weighted average by Cap. | -1.10% | +0.55% | +36.44% | +66.99% |
Historical Quotes: Gilead Sciences, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 124.3 |  | 130.06 |
| 1 month | 112.02 | | 130.06 |
| 3 years | 57.32 | | 132.16 |
| 5 years | 52.29 | | 132.16 |
| 10 years | 46.26 | | 132.16 |
Monthly variations
Annual variations
| 2026 | +22.40% | ||
| 2025 | +17.65% | ||
| 2024 | +23.00% | ||
| 2023 | -8.25% | ||
| 2022 | +22.78% | ||
| 2021 | +40.20% | ||
| 2020 | -21.30% | ||
| 2019 | +7.28% | ||
| 2018 | -9.48% | ||
| 2017 | -12.14% | ||
| 2016 | -26.83% | ||
| 2015 | +17.47% | ||
| 2014 | +48.72% | ||
| 2013 | +97.44% | ||
| 2012 | +74.39% | ||
| 2011 | +14.35% | ||
| 2010 | -9.03% | ||
| 2009 | -16.57% | ||
| 2008 | +14.46% | ||
| 2007 | +27.27% | ||
| 2006 | +11.35% | ||
| 2005 | +70.69% | ||
| 2004 | +11.39% | ||
| 2003 | +41.85% | ||
| 2002 | -9.96% | ||
| 2001 | +69.48% | ||
| 2000 | +63.21% |
- Stock Market
- Stocks
- GILD Stock
- GIS Stock
- Quotes Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
